$ELOX Eloxx Pharmaceuticals, Inc. Insider Trading
Get free email notifications about insider trading in Eloxx Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eloxx Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Eloxx Pharmaceuticals, Inc. for free.
CIK Number: 0001035354
IRS Number: 841368850
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Trading Symbol: ELOX
Company Address: 950 WINTER STREET WALTHAM 02451
Phone number: 858-909-0749
Former name: NAVA LEISURE USA INC, date of change: 1997-03-10
Former name: SENESCO TECHNOLOGIES INC, date of change: 1999-10-06
Former name: Sevion Therapeutics, Inc., date of change: 2014-09-30
Market Capitalization: $4.75M
Prev close: $0.23
Average Daily Volume: 35,194
Days Low: $0.00
Year Low: $0.08
Year High: $0.39
Eloxx Pharmaceuticals, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 20 2021 | ELOX | Eloxx Pharmaceutic ... | PAREKH RAJESH B | Option Exercise | A | 1.48 | 3,334 | 4,934 | 3,334 | ||
May 20 2021 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Option Exercise | A | 1.48 | 20,000 | 29,600 | 20,000 | ||
May 20 2021 | ELOX | Eloxx Pharmaceutic ... | Seehra Jasbir | Option Exercise | A | 1.48 | 20,000 | 29,600 | 20,000 | ||
May 18 2021 | ELOX | Eloxx Pharmaceutic ... | MODUR VIJAY | HEAD OF R&D | Option Exercise | A | 1.41 | 496,204 | 699,648 | 496,204 | |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | PAREKH RAJESH B | Director | Buy | P | 1.35 | 2,381,890 | 3,215,552 | 4,827,129 | 2.4 M to 4.8 M (+97.41 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | PAREKH RAJESH B | Director | Buy | P | 1.35 | 84,776 | 114,448 | 171,807 | 87 K to 171.8 K (+97.41 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 1.35 | 592,592 | 799,999 | 616,592 | 24 K to 616.6 K (+2,469.13 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 1.35 | 1,422,222 | 1,920,000 | 1,989,551 | 567.3 K to 2 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 1.35 | 2,630,487 | 3,551,157 | 3,679,797 | 1 M to 3.7 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Pontifax Management 4 G.P. (20 ... | 10% Owner | Buy | P | 1.35 | 1,280,624 | 1,728,842 | 1,791,470 | 510.8 K to 1.8 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 1.35 | 592,592 | 799,999 | 616,592 | 24 K to 616.6 K (+2,469.13 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 1.35 | 1,422,222 | 1,920,000 | 1,989,551 | 567.3 K to 2 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 1.35 | 2,630,487 | 3,551,157 | 3,679,797 | 1 M to 3.7 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Nussbaum Ran | Director | Buy | P | 1.35 | 1,280,624 | 1,728,842 | 1,791,470 | 510.8 K to 1.8 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 1.35 | 592,592 | 799,999 | 616,592 | 24 K to 616.6 K (+2,469.13 %) |